Physician
Endocrinology
Dr. William T. Cefalu, MD
|
|
Give Review
William Cefalu is an expert in the field of Endocrinology. William T. Cefalu, MD is a published doctor and has 100 publications published. The lastest was: 'Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetolog...'
Publications
- Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetolog...
- Health Policy and Diabetes Care: Is It Time to Put Politics Aside?
- Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 Diabetes.
- Modulation of sphingoLipid metabolism with calorie restriction enhances insulin action in skeletal muscle.
- SGLT2 Inhibitors: The Latest "New Kids on the Block"!
- Isothiocyanate-rich Moringa oleifera extract reduces weight gain, insulin resistance and hepatic gluconeogenesis in mice.
- In vivo effects of dietary quercetin and quercetin-rich red onion extract on skeletal muscle mitochondria, metabolism, and insulin sensitivity.
- Body Mass Index and the Risk of All-Cause Mortality Among Patients with Type 2 Diabetes.
- Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 Diabetes management: reflections from a Diabetes ca...
- Blood pressure and heart failure risk among diabetic patients.
- Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans.
- Chronic binge alcohol consumption alters myogenic gene expression and reduces in vitro myogenic differentiation potential of myoblasts from rhesus macaques.
- Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture.
- Inverse correlation of serum inflammatory markers with metabolic parameters in healthy, black and white pre-pubertal youth.
- Perceptions Community Residents Have about Partner Institutions and Clinical Research.
- HbA1c and Lower-Extremity Amputation Risk in Low-Income Patients With Diabetes.
- Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 Diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a ra...
- Lipid in skeletal muscle myotubes is associated to the donors' insulin sensitivity and physical activity phenoTypes.
- The Importance of Waist Circumference and BMI for Mortality Risk in Diabetic Adults.
- Aggressive Blood Pressure Control Increases Coronary Heart Disease Risk Among Diabetic Patients.
- Blood Pressure and Stroke Risk among Diabetic Patients.
- Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced Obesity mice by enhancing hepatic insulin and AMPK signaling independently of F...
- Signals and Noise in Drug Safety Analyses: The incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance.
- Modulation of cellular insulin signaling and PTP1B effects by Lipid metabolites in skeletal muscle cells.
- An Extract of Artemisia dracunculus L. Inhibits Ubiquitin-Proteasome Activity and Preserves Skeletal Muscle Mass in a Murine Model of Diabetes.
- Comparing the effects of nano-sized sugarcane fiber with cellulose and psyllium on hepatic cellular signaling in mice.
- Reducing the Glycemic Index or Carbohydrate Content of Mixed Meals Reduces Postprandial Glycemia and Insulinemia Over the Entire Day but Does Not Affect Satiety.
- Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans.
- Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with PreDiabetes.
- Proteomic analysis reveals cellular pathways regulating carbohydrate metabolism that are modulated in primary human skeletal muscle culture due to treatment with bioac...
- Evolving treatment strategies for the management of type 2 Diabetes.
- Disrupted Anabolic and Catabolic Processes May Contribute to Alcohol-Accentuated SAIDS-Associated Wasting.
- Impaired Insulin Sensitivity and Elevated Ectopic Fat in Healthy Obese vs. Nonobese Prepubertal Children.
- Tools for the identification of bioactives impacting the metabolic Syndrome: screening of a botanical extract library using subcutaneous and visceral human adipose-der...
- Dietary methionine restriction increases fat oxidation in obese adults with metabolic Syndrome.
- Fractalkine: a cellular link between adipose tissue inflammation and vascular pathologies.
- Inactivation of the mitochondrial carrier SLC25A25 (ATP-Mg2+/Pi transporter) reduces physical endurance and metabolic efficiency in mice.
- Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice.
- Molecular mechanisms for activation of the agouti-related protein and stimulation of appetite.
- An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice.
- Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women.
- Complications of type 1 Diabetes.
- The contribution of race and Diabetes status to metabolic flexibility in humans.
- Translating "Nondiabetic" A1C levels to clinical practice: the art of medicine.
- Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 Diabetes mellitus.
- Current concepts about chromium supplementation in type 2 Diabetes and insulin resistance.
- Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 Diabetes.
- The physiologic role of incretin hormones: clinical applications.
- Redefining treatment success in type 2 Diabetes mellitus: Comprehensive targeting of core defects.
- Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 Diabetes: a 3-year randomized contr...
- How do we define cure of Diabetes?
- Primary prevention of type 2 Diabetes: there are no simple solutions!
- Modulation of skeletal muscle insulin signaling with chronic caloric restriction in cynomolgus monkeys.
- Mortality and glycemic targets in the intensive care unit: another paradigm shift?
- Butyrate improves insulin sensitivity and increases energy expenditure in mice.
- Is it time to change the way we report and discuss weight loss?
- 20-Hydroxyecdysone decreases weight and hyperglycemia in a diet-induced Obesity mice model.
- Inflammation, insulin resistance, and type 2 Diabetes: back to the future?
- Glucose control, macro- and microvascular disease, and the Food and Drug Administration: let's keep our eye on the ball.
- Effects of chromium picolinate on food intake and satiety.
- Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 Diabetes.
- Metabolically favorable remodeling of human adipose tissue by human adenovirus Type 36.
- Multidisciplinary interventions: mapping new horizons in Diabetes care.
- Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol.
- A natural history of botanical therapeutics.
- Botanicals as epigenetic modulators for mechanisms contributing to development of metabolic Syndrome.
- Botanicals and cardiometabolic risk: positioning science to address the hype.
- Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture.
- Effect of Shilianhua extract and its fractions on body weight of obese mice.
- Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet.
- Human adenovirus Type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling.
- Glycemic targets and cardiovascular disease.
- Intensive glycemic control and cardiovascular disease observations from the ACCORD study: now what can a clinician possibly think?
- Phytochemical composition and metabolic performance-enhancing activity of dietary berries traditionally used by Native North Americans.
- Botanicals and the metabolic Syndrome.
- Technologies and experimental approaches at the National Institutes of Health Botanical Research Centers.
- Evaluation of botanicals for improving human health.
- Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet.
- Phenotype of subjects with type 2 Diabetes mellitus may determine clinical response to chromium supplementation.
- Clinical management strategies for type 2 Diabetes.
- Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line.
- The new Diabetes inhalers: new tools for the clinician.
- Clinical research observations with use of exubera in patients with type 1 and 2 Diabetes.
- Point: Pulmonary inhalation of insulin: another "brick in the wall".
- Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age.
- Inactivation of PKCtheta leads to increased susceptibility to Obesity and dietary insulin resistance in mice.
- Bariatric surgery: part of the answer to the Obesity epidemic.
- Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 Diabetes.
- Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats.
- The Hurricane Katrina aftermath and its impact on Diabetes care: observations from "ground zero": lessons in disaster preparedness of people with Diabetes.
- Diabetes, the metabolic Syndrome, and angiographic progression of coronary arterial disease in postmenopausal women.
- Animal models of type 2 Diabetes: clinical presentation and pathophysiological relevance to the human condition.
- Glycemic control and cardiovascular disease--should we reassess clinical goals?
- Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 Diabetes: a randomized, controlled trial.
- Controlling hypoglycemia in type 2 Diabetes: which agent for which patient?
- Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in Diabetes.
- Role of chromium in human health and in Diabetes.
- Caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): metabolic, physiologic, and atherosclerotic measures from a 4-year interventi...
- Concept, strategies, and feasibility of noninvasive insulin delivery.
Schools
Louisiana State University School of Medicine In New Orleans
Conditions Treated
- Adrenal Insufficiency
- Cushing's Syndrome
- Diabetes Type 2
- HyperLipidemia
- View All
Doctors Specialties
- Geriatric Medicine
- Endocrinology
Accepted Insurances
Education
-
UCLA Medical Center -
University of California Irvine
Drug Facts
| NPI NUMBER | 1780908780 | |
| NPPES Provider LastName | CEFALU | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 703801882 | |
| NPPES Provider State | LA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 464.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 5.6 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780908780 |
| Last Name Of The Provider | CEFALU |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Philip M. Oravetz, MD |
|
|
Dr. Guler L. Karcioglu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadda Vidyullatha, MD |
|
Dr. William P. Hudson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jan A. Cooper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marideli C. Scanlan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lumie Kawasaki, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alan L. Burshell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Samuel S. Andrews II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susana L. Dipp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriel Uwaifo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadda R. Reddy, MD
This Doctor is OpenDoctor Recommended.
|